Durand A, Gréa T, Lebeau G, Jacquot G, Tillement A, Aigle A, Thomas E, Kryza D, Taleb J, Ferrauto G, Gianolio E, Géloen A, Montembault A, Guttierez-Blanco M, Pivot X, Harlepp S, Detappe A, David L†, Lux F†, Tillement O†. “Functionalization of chitosan with polycarboxylic macrocycle yields injectable hydrogel with pH and salts responsiveness”. Mater Today Adv, 2025.
Our team develops new ways to diagnose and treat cancer using tiny, smart particles called nanomedicines. By combining advanced imaging and targeted therapies, we aim to detect tumors earlier and make treatments more effective and safer. Our ultimate goal is to bring these innovations quickly from the lab to the clinic, so they can directly benefit patients.
The Genome dynamics and stability team aims to understand how alterations in genome metabolism and stability impact tumorigenesis, cancer progression, treatment choice, and aging.